“We are replacing or repairing the devices related to the Respironics field action as fast as possible and are continuing to update patients and customers about the progress of the program,” David Ferguson, business leader of Philips Respironics, said in the May 24 statement. “More than 1,000 of our colleagues are working around the clock on every aspect of the remediation.”
The FDA is not changing its initial recommendations from June 2021, according to the May 19 notice.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
